Chemistry prize for sustainable drug production
The consequences of malaria continue to kill around 650,000 people every year - mainly children under the age of five. Although there are effective drugs against the infectious disease, many cannot afford them. However, that could soon change. A team led by biochemist Peter H. Seeberger of the Max Planck Institute of Colloids and Interfaces in Potsdam has developed a chemical process that makes the production of artemisinin, the most important antimalarial agent, not only sustainable but also inexpensive.